CP CB-MNC injection — Competitive Intelligence Brief

CP CB-MNC injection (CP CB-MNC injection) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Cell-based therapy. Area: Immunology.

phase 2 Cell-based therapy Immunology Biologic

Target snapshot

CP CB-MNC injection (CP CB-MNC injection) — State-Financed Health Facility "Samara Regional Medical Center Dinasty". CP CB-MNC injection is a cell-based therapy that utilizes mesenchymal stem cells to modulate the immune system.

Comparator set (1 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
CP CB-MNC injection TARGET	CP CB-MNC injection	State-Financed Health Facility "Samara Regional Medical Center Dinasty"	phase 2	Cell-based therapy
co.don chondrosphere®	co.don chondrosphere®	co.don AG	phase 3	Cell-based therapy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Cell-based therapy class)

1. State-Financed Health Facility "Samara Regional Medical Center Dinasty" · 1 drug in this class
2. co.don AG · 1 drug in this class